Detection of unknown primary tumors using whole body FDG PET

Chinese-German Journal of Clinical Oncology

Volumn 2, Issue 3, 2003, Pages 179-183

  Zhao, Jun ^a   Lin, Xiangtong ^a   Guan, Yihui ^a   Zuo, Chuantao ^a   Hua, Fengchun ^a   Sheng, Xiaofang ^b   Wang, Yang ^b  

^a FUDAN UNIVERSITY   (China)

^b Shanghai Xinke Hospital   (China)

Author keywords

Fluorodeoxyglucose; Neoplasm metastasis; Positron emission tomography; Unknown primary tumor

Indexed keywords

EID: 22144443047     PISSN: 16101979     EISSN: 16139089     Source Type: Journal    
DOI: 10.1007/BF02842297     Document Type: Article

References (20)

1. Davidson B J, Spiro RH, Patel S, et al. Cervical metastases of occult origin:the impact of combined modality therapy. Am J Surg, 1994, 168: 395-399.
2. Muir C. Cancer of unknown primary site. Cancer, 1995, 75:353-356.
3. Hainsworth JD, Greco FA. Treatment of patients with cancer of an unknown primary site. N Engl J Med, 1993, 329: 257-263.
4. Maiche AG. Cancer of unknown primary: a retrospective study based on 109 patients. Am J Clin Oncol, 1993, 16: 26-29.
5. Harwick RD. Cervical metastases from an occult primary site. Semin Surg Oncol, 1991, 7: 2-8.
6. Riquet M, Badoual C, Barthes F, et al. Metastatic thoracic lymph node carcinoma with unknown primary site. Ann Thorac Surg, 2003, 75:244-249.
7. De Braud F, Heilbrun LK, Ahmed K, et al. Metastatic squamous cell carcinoma of an unknown primary localized to the neck: advantages of an aggressive treatment. Cancer, 1989, 64: 510-515.
8. Bar-Shalom R, Valdivia AY, Blaufox MD. PET imaging in oncology. Semin Nucl Med, 2000, 30:150-185.
9. Hoh CK, Schiepers C, Seltzer MA, et al. PET in oncology: will it replace the other modalities? Semin Nucl Med, 1997, 27: 94-106.
10. Gambhir SS, Czernin J, Schwinmmeer J, et aL A tabulated summary of the FDG PET. J Nucl Med, 2000, 42: 1s-93s.
11. Reske SN, Kotzerke J. FDG-PET for clinical use. Eur J Nucl Med, 2001, 28: 1707-1723.
12. Coleman RE. Newsline. J Nucl Med, 2000, 41: 36-42.
13. Braams JW, Pruim J, Kole AC, et al. Detection of unknown primary head and neck tumors by positron emission tomography. Int J Oral Maxillofac Surg, 1997, 26: 112-115.
14. Bohuslavizki KH, Klutmann S, Kroger S, et aL FDG PET detection of unknown primary tumors. J Nucl Med, 2000, 41: 816-822.
15. Kole AC, Nieweg OE, Pruim J, et aL Detection of unknown occult primary tumors using positron emission tomography. Cancer, 1998, 82: 1160-1166.
16. Aassar OS, Fischbein N J, Caputo GR, et al. Metastatic head and neck cancer: role and usefulness of FDG PET in locating occult primary tumors. Radiology, 1999, 210: 177-181.
17. Regelink G, Brouwer J, Bree RD, et al. Detection of unknown primary tumours and distant metastases in patients with cervical metastases: value of FDG PET versus conventional modalities. Eur J Ncul Med, 2002, 29: 1024-1030.
18. Padgett HC, Schmidt DG, Luxen A, et al. Computercontrolled radiochemical synthesis: a chemistry process control unit for the automated production of radiochemicals. Appl Radiat Isot, 1989, 40: 433-445.
19. Smith TAD. FDG uptake, tumour characteristics, and response to therapy: a review. Nucl Med Commun, 1998, 19: 97-105.
20. Jeong H J, Chung JK, KimYK, et al. Usefulness of wholebody lSF-FDG PET in patients with suspected metastatic brain tumors. J Nucl Med, 2002, 43: 1432-1437.